Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28054240)

Published in Neurol Ther on January 04, 2017

Authors

Michael Dennis1, Laura Shine2, Ann John3, Amanda Marchant3, Joanna McGregor3, Ronan A Lyons3, Sinead Brophy3

Author Affiliations

1: Farr Institute of Health Informatics Research, Swansea University Medical School, Swansea, Wales, UK. m.s.dennis@swansea.ac.uk.
2: Cwm Taf Health Board, Port Talbot, Wales, UK.
3: Farr Institute of Health Informatics Research, Swansea University Medical School, Swansea, Wales, UK.

Articles cited by this

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA (2005) 10.16

Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract (2010) 7.41

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet (2000) 6.78

The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak (2009) 4.05

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry (2006) 3.83

Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71

The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Serv Res (2009) 3.50

Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ (2012) 3.44

Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ (2010) 3.43

Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ (2004) 3.29

Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med (2008) 3.06

The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry (2013) 3.06

Incidence of Campylobacter and Salmonella infections following first prescription for PPI: a cohort study using routine data. Am J Gastroenterol (2013) 3.00

Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract (2010) 2.93

Delirium in older people. BMJ (2007) 2.77

Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry (2011) 2.59

Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials. Br J Psychiatry (2014) 2.53

The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev (2006) 2.14

Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA (2011) 2.13

Comparative mortality risks of antipsychotic medications in community-dwelling older adults. Br J Psychiatry (2013) 2.05

Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol (2009) 1.86

Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry (2007) 1.86

Don't use antipsychotics routinely to treat agitation and aggression in people with dementia. BMJ (2014) 1.47

Comorbidity scores for administrative data benefited from adaptation to local coding and diagnostic practices. J Clin Epidemiol (2011) 1.46

Antipsychotic-induced venous thromboembolism: a review of the evidence. CNS Drugs (2002) 1.40

Assessment and management of behavioral and psychological symptoms of dementia. BMJ (2015) 1.27

A case study of the Secure Anonymous Information Linkage (SAIL) Gateway: a privacy-protecting remote access system for health-related research and evaluation. J Biomed Inform (2014) 1.26

Neuroleptic drugs in dementia: benefits and harm. Nat Rev Neurosci (2006) 1.23

Association of antipsychotic use with hospital events and mortality among medicare beneficiaries residing in long-term care facilities. Am J Geriatr Psychiatry (2009) 1.17

All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. J Clin Psychiatry (2009) 1.09

Risk of cerebrovascular events in elderly users of antipsychotics. J Psychopharmacol (2008) 0.98

Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study. Pharmacoepidemiol Drug Saf (2014) 0.95

Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. Int J Geriatr Psychiatry (2014) 0.93

Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry (2012) 0.91

Association between prescription of conventional or atypical antipsychotic drugs and mortality in older persons with Alzheimer's disease. Dement Geriatr Cogn Disord (2011) 0.85

The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia. Am J Psychiatry (2016) 0.83

Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis. PLoS One (2014) 0.81

Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia. J Clin Psychopharmacol (2013) 0.81

Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies. Drug Saf (2014) 0.79

Comparison of dementia recorded in routinely collected hospital admission data in England with dementia recorded in primary care. Emerg Themes Epidemiol (2016) 0.77